Page last updated: 2024-11-06

cloquintocet-mexyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cloquintocet-mexyl is a herbicide belonging to the group of phenylpyrazoline compounds. It is used as a pre-emergence herbicide to control a wide range of annual broadleaf weeds in crops such as maize, sorghum, soybeans, and rice. Cloquintocet-mexyl inhibits the biosynthesis of the amino acid valine, which is essential for plant growth. This inhibition leads to the death of weeds. Cloquintocet-mexyl is considered to be a selective herbicide, meaning that it is toxic to weeds but not to the crop plants. The mode of action is inhibition of the enzyme acetolactate synthase (ALS), also known as acetohydroxyacid synthase (AHAS), which is involved in the biosynthesis of the branched-chain amino acids valine, leucine, and isoleucine. Research on cloquintocet-mexyl focuses on its effectiveness as a herbicide, its environmental fate, and its potential for resistance development. The compound is studied to understand its impact on non-target organisms, such as beneficial insects and aquatic life. The environmental fate of cloquintocet-mexyl is also investigated to assess its persistence in soil and water, as well as its potential for bioaccumulation in the food chain.'

cloquintocet-mexyl: an herbicide safener [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cloquintocet-mexyl : A racemate composed of equimolar amounts of (R)- and (S)-cloquintocet-mexyl. It is a colourless crystalline herbicide safener which protects small cereal crops against the toxicity of the herbicide clodinafop-propargyl. The World Health Organization have categorized it as a class III toxin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate : A member of the class of quinolines that is quinoline which is substituted by a chloro group at position 5 and by a 2-[(heptan-2-yl)oxy]-2-oxoethoxy group at position 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID93528
CHEMBL ID3185510
CHEBI ID143155
SCHEMBL ID96159
MeSH IDM0503575

Synonyms (56)

Synonym
99607-70-2
cloquintocet-mexyl [iso]
cloquintocet-mexyl
1-methylhexyl (5-chloroquinolin-8-yloxy)acetate
AKOS005082550
1-methylhexyl 2-[(5-chloro-8-quinolinyl)oxy]acetate
CHEBI:143155
heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate
2-heptyl 2-(5-chloro-8-quinolinyloxy)acetate
heptan-2-yl 2-(5-chloroquinolin-8-yl)oxyacetate
A846051
[(1s)-1-methylhexyl] 2-[(5-chloro-8-quinolyl)oxy]acetate
cas-99607-70-2
dtxcid1021794
NCGC00255554-01
tox21_301561
dtxsid3041794 ,
2-heptyl 2-[(5-chloroquinolin-8-yl)oxy]acetate
C2682
2-[(5-chloroquinolin-8-yl)oxy]acetic acid 2-heptyl ester
ec 619-447-3
(rs)-1-methylhexyl (5-chloroquinolin-8-yloxy) acetate
acetic acid, 2-((5-chloro-8-quinolinyl)oxy)-, 1-methylhexyl ester
unii-99w15eh2m3
99w15eh2m3 ,
acetic acid, ((5-chloro-8-quinolinyl)oxy)-, 1-methylhexyl ester
FT-0642401
(+/-)-cloquintocet-mexyl
cloquintocet-mexyl, (+/-)-
cga-185072
cloquintocet 1-methylhexyl ester
cloquintocet-mexyl [mi]
(rs)-1-methylhexyl (5-chloroquinolin-8-yloxy)acetate
SCHEMBL96159
heptan-2-yl 2-[(5-chloroquinolin-8-yl)oxy]acetate
1J-317S
cloquintocet mexyl
HY-B2024
CS-5215
heptan-2-yl 2-((5-chloroquinolin-8-yl)oxy)acetate
CHEMBL3185510
cloquintocetmexyl
J-521430
acetic acid, [(5-chloro-8-quinolinyl)oxy]-, 1-methylhexyl ester
AC-9079
cloquintocet-mexyl, pestanal(r), analytical standard
H11935
cloquintocet-1-methylhexyl ester
cloquintocet-1-methylhexyl ester 10 microg/ml in acetonitrile
heptan-2-yl 2-(5-chloroquinolin-8-yloxy)acetate
Q2979582
mfcd01632329
cloquintocet mexyl; 1-methylhexyl (5-chloroquinolin-8-yloxy)acetate
BCP14267
SY036320
2-heptyl2-(5-chloro-8-quinolinyloxy)acetate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"In plants potentially toxic compounds are ultimately deposited in the large central vacuole."( A herbicide antidote (safener) induces the activity of both the herbicide detoxifying enzyme and of a vacuolar transporter for the detoxified herbicide.
Amrhein, N; Dufaud, A; Gaillard, C; Kreuz, K; Martinoia, E; Tommasini, R, 1994
)
0.29

Compound-Compound Interactions

ExcerptReferenceRelevance
" Based on the chiral HPLC method, enantioselective quantitative determination analysis methods for this herbicide combined with CP in diluted plasma were developed and validated."( Direct chiral resolution of cloquintocet-mexyl and its application to in vitro degradation combined with clodinafop-propargyl.
Liu, D; Shen, Z; Xu, X; Zhou, Z; Zhu, W, 2012
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
quinolinesA class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring.
carboxylic esterAn ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (21)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency61.13060.006038.004119,952.5996AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency54.48270.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency60.78650.000221.22318,912.5098AID1259243; AID1259247; AID743035
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency43.27710.000657.913322,387.1992AID1259378
progesterone receptorHomo sapiens (human)Potency54.48270.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency30.89560.000214.376460.0339AID720691
retinoid X nuclear receptor alphaHomo sapiens (human)Potency30.89560.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency57.77480.001530.607315,848.9004AID1224848; AID1224849; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency61.64480.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency24.33650.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.76530.000229.305416,493.5996AID1259244; AID743069
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency54.94100.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency54.94100.001019.414170.9645AID743191
aryl hydrocarbon receptorHomo sapiens (human)Potency54.48270.000723.06741,258.9301AID743085
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency76.95880.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency43.641219.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency26.35950.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency64.86010.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency56.01570.042027.378961.6448AID743210; AID743228
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency68.58960.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency68.58960.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.22 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index67.11 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (47.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]